Biogen Backs Alzheimer’s Tau Drug for Phase 3 Despite Trial Miss

Biogen (NASDAQ:BIIB) said data from its Phase 2 CELIA study of diranersen in early Alzheimer’s disease provide proof of ...

Biogen Shares Rise After Positive Phase 2 Alzheimer’s Trial Results (BIIB)

Biogen Inc. (NASDAQ:BIIB) traded higher after releasing encouraging Phase 2 data for its experimental Alzheimer’s treatment, ...

How does Biogen’s novel Alzheimer’s drug compare to approved drugs

Biogen (BIIB) stock falls as latest mid-stage trial data for Alzheimer’s drug diranersen developed with Ionis Pharmaceuticals ...
The Manila Times

Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease

Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent results across multiple prespecified clinical endpoints; the 60 mg dose showed the strongest response with ...

‘Landmark’ study to see blood test for Alzheimer’s offered by GPs

‘Landmark’ study to see blood test for Alzheimer’s offered by GPs - Dementia affects about 90,000 people in Scotland, an ...

Why is Biogen stock falling Tuesday?

Biogen Inc. BIIB on Tuesday said it will advance investigational Alzheimer’s therapy diranersen into Phase 3 testing after ...

Chinese University of Hong Kong enters top 20 in QS World University rankings

The Chinese University of Hong Kong (CUHK) ranks 18th globally, entering the global top 20 for the first time. This milestone ...
WSB-TV

WSB-TV Atlanta news, traffic, weather and sports

Neighbors say several drivers have crashed into the barriers meant to protect bikers.